Facebook
Twitter
LinkedIn
Forward
Assessing and Addressing Barriers to ART Adherence
Because HIV is a chronic disease that requires lifelong treatment, it is essential that people living with HIV regularly visit their healthcare provider (HCP) and adhere to recommended treatment protocols. Newer types of potent antiretrovirals and their combinations, including once-daily treatment, have simplified treatment regimens and diminished side effects. Still, adherence to antiretroviral therapy (ART) remains unsatisfactory. Reasons for poor adherence are multifactorial; solutions can be complex and require the involvement of the multidisciplinary care team.
Join Johnathan Appelbaum, MD, and Rajesh Gandhi, MD, as they discuss data supporting the need for adequate adherence to ART for successful HIV outcomes and how HCPs can identify and help overcome barriers to adherence. The faculty examine 2 different case studies featuring individuals with HIV infection, as well as the unique characteristics and comorbidities of each that may potentially impact adherence, and provide their perspectives on how HIV clinicians can help mitigate some of these issues for optimal treatment outcomes.
Target Audience
Infectious disease specialists, family and internal medicine MDs/DOs, nurse practitioners (NPs), physician assistants (PAs), and other clinicians with an interest in HIV management
Learning Objectives
- Review the current recommendations for treatment of HIV-positive patients, including the need for adequate therapeutic adherence
- Implement patient-centered strategies to improve adherence to antiretroviral therapy
Additional Information
Jonathan S. Appelbaum, MD, FACP, MHIVS
Professor and Chair, Department of Clinical Sciences
Florida State University College of Medicine
Tallahassee, FL
Dr. Appelbaum is on the advisory boards of Merck & Co., Inc., and ViiV Healthcare.
Rajesh Gandhi, MD
Professor of Medicine, Harvard Medical School
Director, HIV Clinical Services and Education
Massachusetts General Hospital
Boston, MA
Dr. Gandhi is on the advisory board for Merck & Co., Inc.
Conflict of Interest Disclosure Policy
In accordance with the ACCME Standards for Commercial Support, Albert Einstein College of Medicine and Haymarket Medical Education (HME) require that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. HME and Albert Einstein College of Medicine resolve all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all their educational activities.
Disclosure of Unlabeled Use
This CME activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options for a specific patient's medical condition.
Commercial Supporters
Supported by an educational grant from Janssen Therapeutics.
Albert Einstein College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AMA PRA Category 1 CreditTM
Accreditation Statement
Albert Einstein College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation Statement
Albert Einstein College of Medicine designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of 0.25 Category 1 Credit for completing this activity.
The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts certificates of participation for education activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME. Individuals are responsible for checking with the AANPCP for further guidelines.
Accredited Provider Disclosure
The staff of the Center for Continuing Medical Education of Albert Einstein College of Medicine has nothing to disclose with regard to commercial support.
Barry Zingman, MD, course reviewer of Albert Einstein College of Medicine has nothing to disclose with regard to commercial support.
Haymarket Medical Education staff involved in the planning and content review of this activity have no relevant financial relationships to disclose.
Available Credit
- 0.25 AMA PRA Category 1 Credit™
This course is offered through MyCME. To take this course you will be redirected to MyCME's website. You must have an account with MyCME in order to complete this activity.
MOCINGBIRD continues to work with our CME partner network to provide courses directly to you. We appreciate your patience as we work toward that goal!